Cargando…
The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis
Solute carriers are increasingly recognized as participating in a plethora of pathologies, including cancer. We describe here the involvement of the orphan solute carrier Major Facilitator Superfamily Domain-containing protein 1 (MFSD1) in the regulation of tumor cell migration. Loss of MFSD1 enable...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861502/ https://www.ncbi.nlm.nih.gov/pubmed/35211397 http://dx.doi.org/10.3389/fonc.2022.777634 |
_version_ | 1784654902240215040 |
---|---|
author | Roblek, Marko Bicher, Julia van Gogh, Merel György, Attila Seeböck, Rita Szulc, Bozena Damme, Markus Olczak, Mariusz Borsig, Lubor Siekhaus, Daria E. |
author_facet | Roblek, Marko Bicher, Julia van Gogh, Merel György, Attila Seeböck, Rita Szulc, Bozena Damme, Markus Olczak, Mariusz Borsig, Lubor Siekhaus, Daria E. |
author_sort | Roblek, Marko |
collection | PubMed |
description | Solute carriers are increasingly recognized as participating in a plethora of pathologies, including cancer. We describe here the involvement of the orphan solute carrier Major Facilitator Superfamily Domain-containing protein 1 (MFSD1) in the regulation of tumor cell migration. Loss of MFSD1 enabled higher levels of metastasis in experimental and spontaneous metastasis mouse models. We identified an increased migratory potential in MFSD1(−/−) tumor cells which was mediated by increased focal adhesion turnover, reduced stability of mature inactive β1 integrin, and the resulting increased integrin activation index. We show that MFSD1 promoted recycling to the cell surface of endocytosed inactive β1 integrin and thereby protected β1 integrin from proteolytic degradation; this led to dampening of the integrin activation index. Furthermore, downregulation of MFSD1 expression was observed during the early steps of tumorigenesis, and higher MFSD1 expression levels correlate with a better cancer patient prognosis. In sum, we describe a requirement for endolysosomal MFSD1 in efficient β1 integrin recycling to suppress tumor cell dissemination. |
format | Online Article Text |
id | pubmed-8861502 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88615022022-02-23 The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis Roblek, Marko Bicher, Julia van Gogh, Merel György, Attila Seeböck, Rita Szulc, Bozena Damme, Markus Olczak, Mariusz Borsig, Lubor Siekhaus, Daria E. Front Oncol Oncology Solute carriers are increasingly recognized as participating in a plethora of pathologies, including cancer. We describe here the involvement of the orphan solute carrier Major Facilitator Superfamily Domain-containing protein 1 (MFSD1) in the regulation of tumor cell migration. Loss of MFSD1 enabled higher levels of metastasis in experimental and spontaneous metastasis mouse models. We identified an increased migratory potential in MFSD1(−/−) tumor cells which was mediated by increased focal adhesion turnover, reduced stability of mature inactive β1 integrin, and the resulting increased integrin activation index. We show that MFSD1 promoted recycling to the cell surface of endocytosed inactive β1 integrin and thereby protected β1 integrin from proteolytic degradation; this led to dampening of the integrin activation index. Furthermore, downregulation of MFSD1 expression was observed during the early steps of tumorigenesis, and higher MFSD1 expression levels correlate with a better cancer patient prognosis. In sum, we describe a requirement for endolysosomal MFSD1 in efficient β1 integrin recycling to suppress tumor cell dissemination. Frontiers Media S.A. 2022-02-08 /pmc/articles/PMC8861502/ /pubmed/35211397 http://dx.doi.org/10.3389/fonc.2022.777634 Text en Copyright © 2022 Roblek, Bicher, van Gogh, György, Seeböck, Szulc, Damme, Olczak, Borsig and Siekhaus https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Roblek, Marko Bicher, Julia van Gogh, Merel György, Attila Seeböck, Rita Szulc, Bozena Damme, Markus Olczak, Mariusz Borsig, Lubor Siekhaus, Daria E. The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis |
title | The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis |
title_full | The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis |
title_fullStr | The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis |
title_full_unstemmed | The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis |
title_short | The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis |
title_sort | solute carrier mfsd1 decreases the activation status of β1 integrin and thus tumor metastasis |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861502/ https://www.ncbi.nlm.nih.gov/pubmed/35211397 http://dx.doi.org/10.3389/fonc.2022.777634 |
work_keys_str_mv | AT roblekmarko thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis AT bicherjulia thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis AT vangoghmerel thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis AT gyorgyattila thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis AT seebockrita thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis AT szulcbozena thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis AT dammemarkus thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis AT olczakmariusz thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis AT borsiglubor thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis AT siekhausdariae thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis AT roblekmarko solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis AT bicherjulia solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis AT vangoghmerel solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis AT gyorgyattila solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis AT seebockrita solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis AT szulcbozena solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis AT dammemarkus solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis AT olczakmariusz solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis AT borsiglubor solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis AT siekhausdariae solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis |